FP7
IPIE
Intelligent Assessment of Pharmaceutical in the Environment
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 54 months
- Total cost
- EUR 10,345,016
- EU contribution
- EUR 3,000,000
- Participants
- 22 from 9 countries
- Topic
- FP7_IMI-JU-11-2013-08
- Grant agreement
- 115735
Coordinated by Bayer Aktiengesellschaft (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Bayer Aktiengesellschaft | DEGermany | Coordinator | Not stated | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| Ect Oekotoxikologie GmbH | DEGermany | Participant | EUR 332,459 | PIC (1.00) |
| Helmholtz-Zentrum Fur Umweltforschung GmbH - UFZ | DEGermany | Participant | EUR 262,862 | known name (0.97) |
| Molecular Networks GmbH Computerchemie | DEGermany | Participant | EUR 258,475 | PIC (1.00) |
| Umweltbundesamt | DEGermany | Participant | EUR 186,677 | known name (0.97) |
| Fundacio Institut Hospital del Mar D Investigacions Mediques | ESSpain | Participant | EUR 150,157 | known name (0.97) |
| Synapse Research Management Partners SL | ESSpain | Participant | EUR 224,866 | PIC (1.00) |
| Universidad Pompeu Fabra | ESSpain | Participant | EUR 125,583 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Lhasa Limited | GBUnited Kingdom | Participant | EUR 288,640 | PIC (1.00) |
| The University of Exeter | GBUnited Kingdom | Participant | EUR 258,566 | PIC (1.00) |
| University of York | GBUnited Kingdom | Participant | EUR 394,255 | known name (0.95) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 360,400 | known name (0.95) |
| Teva Pharmaceuticals Europe B.V. | NLNetherlands | Participant | Not stated | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Bristol-Myers Squibb Company Corp | USUnited States | Participant | Not stated | PIC (1.00) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 22 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.